IL6 and neoplasm: Eighteen studies of patients with colorectal cancer [24, 65, 84–99] assessed the correlation between circulating IL-6 and clinical characteristics, reporting ambiguous results regarding tumor stage, resectability of the tumor, lymph node metastases, distant metastases, TNM stage and vascular invasion with 11 out of 18 articles finding correlation.